Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  Fresenius SE & Co KGaA    FRE   DE0005785604

Delayed Quote. Delayed  - 07/22 05:35:17 pm
67.15 EUR   +0.39%
05:18p JPD : Public comments welcome for international accreditation
07/23 BRIEF : Lexington police seek feedback during accreditation
07/18 UNION PACIFIC : Seeks Public Comment for CALEA Accreditation of Resp..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Fresenius Sets Pricing On EUR500 Million 7-Year Bond At 4.25% Area

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/21/2012 | 01:24pm CEST

("Fresenius Sets Pricing On EUR500M 7-Year Bond At 4.25% Area," at 1020 GMT, misstated the vehicle issuing the bond in the first paragraph. The correct version follows:)

-German medical care company Fresenius SE & CO. KGaA (>> Fresenius SE & Co KGaA) has set price guidance on its EUR500 million seven-year bond in the area of 4.25%, one of the banks on the deal said Wednesday.

The issue will be priced later Wednesday, and books on the deal are comfortably oversubscribed, said one of the banks on the deal. The issue was primarily targeted at retail accounts, which showed a good deal of interest, it added.

The bond will be used--among other corporate purposes--to fund the acquisition of hospital operator Damp Group, which Fresenius acquired in October 2011.

Expected ratings are Ba1 from Moody's Investors Service and BB+ from Standard & Poor's Corp. and Fitch Ratings.

Royal Bank of Scotland Group PLC, Deutsche Bank AG, Commerzbank AG, LBBW and Bayern LB are lead managers on the deal.

-By Serena Ruffoni, Dow Jones Newswires; +44 (0) 207 842 9349; serena.ruffoni@dowjones.com

Stocks mentioned in the article : Fresenius SE & Co KGaA
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FRESENIUS SE & CO KGAA
05:18p JPD : Public comments welcome for international accreditation
07/23 BRIEF : Lexington police seek feedback during accreditation
07/18 UNION PACIFIC : Seeks Public Comment for CALEA Accreditation of Response Managem..
07/15 FRESENIUS SE KGAA : Police plan for active shooter responses
07/11 FRESENIUS SE KGAA : Law enforcement team wants to hear from Albertans
07/08 FRESENIUS SE KGAA : Sheriff's Office seeks comments from members of the local co..
07/06 FRESENIUS SE KGAA : Sheriff's Office seeks comments from the community
06/30 BRIEF : Sheriff's Office invites public comment for accreditation
06/28DJNestlé Turns to Health Sector for Next CEO -- WSJ
06/27 FRESENIUS SE KGAA : Nestle poaches CEO from Fresenius in health and wellness dri..
More news
Sector news : Hospitals, Clinics & Primary Care Services
07/21DJQUEST DIAGNOSTICS : Profit Rises, Helped by Lower Costs
06/24DJSources Say Fresenius May Acquire Pfizer Medical Devices Arm for About $1.5 B..
06/06DJQUEST DIAGNOSTICS : to Move Headquarters to Secaucus
05/31DJIHH HEALTHCARE BHD : Malaysia Khazanah Nasional Seeks to Raise Up to $204 Millio..
05/31DJIHH HEALTHCARE BHD : Malaysia's Khazanah Nasional Seeks to Raise Up to $204 Mill..
More sector news : Hospitals, Clinics & Primary Care Services
News from SeekingAlpha
07/01 A NEW SOURCE FOR DIVIDEND GROWTH INV : The German Dividend Aristocrats
06/27 Nestle appoints Fresenius?s Schneider as new CEO
06/24 DAVITA HEALTHCARE VS. FRESENIUS MEDI : Why I Wouldn't Follow Buffett This Time
02/28 Fresenius Medical Care's (FSNUY) Chairman Mark Schneider on Q4 2015 Results -..
02/24 Fresenius SE & Co. KGaA ADR reports Q4 results
Advertisement
Financials (€)
Sales 2016 29 275 M
EBIT 2016 4 359 M
Net income 2016 1 598 M
Debt 2016 12 952 M
Yield 2016 0,99%
P/E ratio 2016 23,08
P/E ratio 2017 20,87
EV / Sales 2016 1,70x
EV / Sales 2017 1,55x
Capitalization 36 683 M
More Financials
Chart FRESENIUS SE & CO KGAA
Duration : Period :
Fresenius SE & Co KGaA Technical Analysis Chart | FRE | DE0005785604 | 4-Traders
Full-screen chart
Technical analysis trends FRESENIUS SE & CO...
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 70,0 €
Spread / Average Target 4,2%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stephan Sturm Chief Executive Officer
Gerd Krick Chairman-Supervisory Board
Niko Stumpfögger Member-Supervisory Board
Dario Anselmo Ilossi Member-Supervisory Board
Klaus-Peter Müller Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
FRESENIUS SE & CO KGAA1.79%40 259
IHH HEALTHCARE BHD--.--%13 138
RAMSAY HEALTH CARE LIM..14.01%11 670
MEDICLINIC INTERNATION..37.67%10 598
BANGKOK DUSIT MEDICAL ..--.--%10 336
AIER EYE HOSPITAL GROU..--.--%5 571
More Results